- Home
- MVIS vs KOD Comparison
MVIS vs KOD Comparison
Compare MVIS & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MVIS
- KOD
- Stock Information
- Founded
- MVIS 1993
- KOD 2009
- Country
- MVIS United States
- KOD United States
- Employees
- MVIS N/A
- KOD N/A
- Industry
- MVIS Industrial Machinery/Components
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MVIS Technology
- KOD Health Care
- Exchange
- MVIS Nasdaq
- KOD Nasdaq
- Market Cap
- MVIS 287.6M
- KOD 259.6M
- IPO Year
- MVIS 1996
- KOD 2018
- Fundamental
- Price
- MVIS $1.12
- KOD $3.48
- Analyst Decision
- MVIS Buy
- KOD Hold
- Analyst Count
- MVIS 4
- KOD 3
- Target Price
- MVIS $2.50
- KOD $9.00
- AVG Volume (30 Days)
- MVIS 4.8M
- KOD 440.1K
- Earning Date
- MVIS 05-12-2025
- KOD 05-14-2025
- Dividend Yield
- MVIS N/A
- KOD N/A
- EPS Growth
- MVIS N/A
- KOD N/A
- EPS
- MVIS N/A
- KOD N/A
- Revenue
- MVIS $4,329,000.00
- KOD N/A
- Revenue This Year
- MVIS $481.03
- KOD N/A
- Revenue Next Year
- MVIS $95.03
- KOD N/A
- P/E Ratio
- MVIS N/A
- KOD N/A
- Revenue Growth
- MVIS N/A
- KOD N/A
- 52 Week Low
- MVIS $0.80
- KOD $1.92
- 52 Week High
- MVIS $1.95
- KOD $11.60
- Technical
- Relative Strength Index (RSI)
- MVIS 47.51
- KOD 44.47
- Support Level
- MVIS $1.10
- KOD $3.46
- Resistance Level
- MVIS $1.38
- KOD $3.81
- Average True Range (ATR)
- MVIS 0.10
- KOD 0.40
- MACD
- MVIS 0.01
- KOD -0.07
- Stochastic Oscillator
- MVIS 30.26
- KOD 31.58
About MVIS MicroVision Inc.
Microvision Inc is engaged in developing a lidar sensor to be used in automotive safety and autonomous driving applications. Its lidar sensor uses laser beam scanning (LBS) technology, which is based on systems that include micro-electrical mechanical systems (MEMS), laser diodes, opto-mechanics, electronics, algorithms, and software. The company has also developed solutions for Augmented Reality, Interactive Displays, and Consumer Lidars.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.